T. Rowe Price Associates
CADL icon

T. Rowe Price Associates’s Candel Therapeutics CADL Stock Holding History

T. Rowe Price Associates’s Portfolio CADL Stock Details CADL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$100K Buy
19,638
+7,363
+60% +$37.5K ﹤0.01% 2890
2025
Q1 		$70K Buy
+12,275
New +$70K ﹤0.01% 2883